On February 27, Maxx Orthopedics Inc. reported that it entered into an agreement to acquire TracPatch from Granger Group.
TracPatch is a non-invasive, FDA Class I exempt medical device that provides a digital health solution designed to provide accessible, connected and more predictable recovery. It provides surface-sensor, remote patient monitoring devices and data capture for musculoskeletal health. Granger Group purchased TracPatch in August 2023 for an undisclosed price.
Maxx Orthopedics is a manufacturer and developer of orthopedic medical devices and integrated solutions designed to restore mobility while addressing patient lifestyle, anatomical and economic considerations.
“Adding a proven technology like TracPatch® to our platform advances our mission to equip surgeons with the tools and support necessary to personalize care and deliver predictable outcomes,” said Ashesh Shah, CEO of Maxx Orthopedics. “By integrating real-time recovery monitoring within our QRS platform, we are strengthening the full continuum of care and reinforcing our commitment to helping patients Pursue Life.”
According to data captured in the LevinPro, this deal represents the 43rd eHealth acquisition of the year, and the third in the remote patient monitoring (RPM) subsector. In 2025, 31 RPM deals were announced.
